Details for New Drug Application (NDA): 009372
✉ Email this page to a colleague
NDA 009372 describes ANSOLYSEN, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the ANSOLYSEN profile page.
The generic ingredient in ANSOLYSEN is pentolinium tartrate. There is one drug master file entry for this compound. Additional details are available on the pentolinium tartrate profile page.
The generic ingredient in ANSOLYSEN is pentolinium tartrate. There is one drug master file entry for this compound. Additional details are available on the pentolinium tartrate profile page.
Summary for 009372
| Tradename: | ANSOLYSEN |
| Applicant: | Wyeth Ayerst |
| Ingredient: | pentolinium tartrate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 009372
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 10MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
